| abstract |
The present invention relates generally to immunogenic compositions (eg, vaccines), particularly multivalent immunogenic compositions, such as multivalent HIV vaccines, and methods of using the same. The invention further relates to a method of generating a multivalent antigen set suitable for use, for example, in vaccination therapy using a genetic algorithm. [Selection figure] None |